2025 annual results: Equasens reports a solid performance across all financial indicators

About this update from Equasens Sa

[{"type":"image","alt":"EQUASENS","displaySize":"","headline":null,"caption":"EQUASENS","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":199,"url":"https://media.zenfs.com/en/globenewswire.com/cd953bb219d7123a3201338702f0890e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uWLv7O.lts.QEy69ZmwaPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI3OQ--/https://media.zenfs.com/en/globenewswire.com/cd953bb219d7123a3201338702f0890e","width":300,"height":199}},"lazy":false},{"type":"text","content":"Villers-lès-Nancy, 30 March 2026 - 08:00 (CEST)","length":47,"tagName":"p"},{"type":"text","content":"PRESS RELEASE","length":13,"tagName":"p"},{"type":"text","content":"        ","length":48,"tagName":"p"},{"type":"text","content":"2025 annual resultsEquasens reports a solid performanceacross all financial indicators","length":88,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"FY 2025 revenue of €236.5 million (+9.1%): continued strong performance driven by a portfolio of innovative solutions for healthcare professionals and providers  ","length":165,"tagName":"p"}]},{"val":[{"type":"text","content":"Annual Recurring Revenue (ARR) up sharply: €108.0 million at December 31, 2025, representing 8.8% growth versus 2024 ","length":116,"tagName":"p"}]},{"val":[{"type":"text","content":"EBITDA of €66.7 million (+9.1%), highlighting effective cost control in a sustained growth environment","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"Current operating income of €48.2 million (+6.8%), including the impact of investments in the new healthcare data infrastructure ","length":128,"tagName":"p"}]},{"val":[{"type":"text","content":"Net profit increased by 8.8% to €41.1 million, supporting the proposed distribution of a €1.40 gross dividend per share for FY 2025, subject to approval by the General Meeting on June 25, 2026","length":192,"tagName":"p"}]},{"val":[{"type":"text","content":"Continued M&A activity and technology investment, alongside an improved net cash position of €83.6 million at year-end 2025 (+€4.1 million) ","length":143,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":846,"olType":false},{"type":"text","content":"Villers-lès-Nancy, March 30, 2026, 08:00 CEST – Equasens (ISIN: FR0012882389 – Ticker: EQS), a leading provider of ...

More updates from Equasens Sa